Last $19.42 USD
Change Today +0.88 / 4.75%
Volume 957.1K
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Kleanthis Xanthopoulos Ph.D.137 RelationshipsChief Executive Officer, President, Principal Financial & Accounting Officer and DirectorChief Executive Officer56

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Stelios Papadopoulos Ph.D. 100 RelationshipsChairman of the BoardExelixis, Inc.66
David Baltimore Ph.D. 117 RelationshipsMember of the Board of DirectorsAriad Pharmaceuticals Inc.76
Bruce Carter Ph.D. 213 RelationshipsMember of the Board of DirectorsXencor, Inc.71
Mark Foletta CPA 37 RelationshipsMember of the Board of DirectorsIslet Sciences, Inc53
David Bartel Ph.D. 28 RelationshipsMember of Advisory BoardRegulus Therapeutics Inc.--
Markus Stoffel M.D., Ph.D. 26 RelationshipsMember of Advisory BoardPanCel Corporation--
Thomas Tuschl Ph.D. 25 RelationshipsMember of Advisory BoardAlnylam Pharmaceuticals, Inc.--
B. Parshall Esq., J.D. 47 RelationshipsMember of the Board of DirectorsIsis Pharmaceuticals, Inc.60
Gregory Hannon Ph.D. 15 RelationshipsMember of Advisory BoardRegulus Therapeutics Inc.--
Douglas Williams Ph.D. 72 RelationshipsMember of the Board of DirectorsBiogen Idec Inc.56
William Rastetter Ph.D. 104 RelationshipsMember of the Board of DirectorsReceptos, Inc.66
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $19.42 USD +0.88

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.80 AUD -0.025
Galena Biopharma Inc $1.72 USD +0.06
Prosensa Holding NV $18.95 USD +0.13
Silence Therapeutics PLC 226.00 GBp +1.25
Tekmira Pharmaceuticals Corp C$31.80 CAD +0.61
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 57.7x
Price/Book 9.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 56.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.